论文信息 - Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2) - 字舞流文

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)

M. Berger | S. Loi | S. Chandarlapaty | J. Baselga | D. Solit | P. Savas | P. Razavi | H. Won | D. Hyman | K. Papadopoulos | M. Wick | M. Scaltriti | F. Montemurro | V. Rossi | E. Toska | J. Soong | E. Cocco | Yanyan Cai | A. Lalani | I. Sarotto | V. Boni | R. Cutler | R. Bryce | Sophie G. Shifman | Francesca Avogadri-Connors | Carmen Chan | A. Moriarty | J. Cownie | F. Javier Carmona